Congestive Heart Failure

Related by string. congestive heart failure * congestive : Congestive heart failure . congestive heart . congestive cardiac . hypertension congestive heart / hearts . Hearts . HEART . hearted : heart disease . light hearted . Heart Attack . National Heart Lung / Failures . FAILURE . failures . FAILURES : chronic renal failure . tracks EVERY failure . acute renal failure . kidney failure * *

Related by context. All words. (Click for frequent words.) 69 Heart Failure Patients 69 Heart Failure 68 Chronic Heart Failure 68 Acute Myocardial Infarction 67 Acute Decompensated Heart Failure 67 Acute Ischemic Stroke 67 Subgroup Analysis 66 Pulmonary Arterial Hypertension 65 Diabetic Patients 65 Overactive Bladder 64 Acute Renal Failure 64 Infarction 64 Peripheral Artery Disease 64 Cardiovascular Outcomes 64 Meets Primary Endpoint 64 Relapsing Multiple Sclerosis 63 Patient Outcomes 63 Patients Undergoing 63 Ischemic Stroke 63 Coronary Angiography 63 Septic Shock 63 Acute Coronary Syndrome 63 Rheumatoid Arthritis Patients 63 Chronic Sinusitis 63 Ischemic 63 Severe Sepsis 63 Myocardial Ischemia 63 Prospective Randomized 63 Acute Coronary Syndromes 63 Coronary Artery Bypass Graft 63 ACE Inhibitors 63 Chronic Myeloid Leukemia 63 Improve Survival 63 Metastatic Prostate Cancer 63 Elderly Patients 63 Left Ventricular 63 Allergic Rhinitis 62 Catheter Ablation 62 Beta Blocker 62 Dupuytren Contracture 62 Mitral Regurgitation 62 Stent Thrombosis 62 Chronic Lymphocytic Leukemia 62 Ischemia 62 Relapsing Remitting Multiple Sclerosis 62 dual endothelin receptor antagonist 62 Obstructive Sleep Apnea 62 systolic hypertension 62 Randomized Study 62 Secondary Hyperparathyroidism 62 Myelodysplastic Syndromes 62 Acute Heart Failure 62 Recurrent Stroke 62 Juvenile Idiopathic Arthritis 62 Oral Fingolimod 62 Carotid Stenting 62 Randomized Evaluation 62 Diabetic Macular Edema 62 Breast Cancer Recurrence 62 Stenosis 62 Disease Progression 62 Resistant Hypertension 61 Infarct 61 Radiofrequency Ablation 61 Hospital Acquired Pneumonia 61 Diastolic Heart Failure 61 Liver Metastases 61 Critical Limb Ischemia 61 Renal Cell Carcinoma 61 Pelvic Organ Prolapse 61 Nesiritide 61 Long Term Efficacy 61 Lung Function 61 Patients Receiving 61 ST Segment Elevation 61 Balloon Angioplasty 61 Peripheral Arterial Disease 61 Lung Cancer Patients 61 Unresectable 61 Multicenter Randomized 61 Improves Outcomes 61 ST Elevation Myocardial 61 Coronary Disease 61 Drug Eluting Stents 61 Hematological 61 Percutaneous Coronary Intervention 61 Acute Myocardial 61 Clinical Outcome 61 Valve Replacement 61 Iron Overload 61 Unstable Angina 61 Minimally Invasive Treatment 61 Renal Artery 61 Hyperkalemia 61 Cardiotoxicity 61 Prophylactic Treatment 61 Valvular Heart Disease 61 Kidney Failure 61 Clinical Trial Results 61 Newly Diagnosed Multiple Myeloma 61 Glucose Monitoring 60 Atrial Fibrillation 60 Obese Patients 60 Community Acquired Pneumonia 60 Hospitalized Patients 60 Coronary Artery 60 Proven Effective 60 Metastatic Melanoma 60 Cardiac Resynchronization Therapy 60 Diabetes Mellitus 60 Cognitive Impairment 60 Reperfusion Injury 60 NYHA Class II 60 Rheumatoid Arthritis RA 60 Lung Injury 60 Combination Treatment 60 Anticoagulant 60 Lupus Nephritis 60 Dialysis Patients 60 Sleep Disturbances 60 Improve Outcomes 60 Treatment Resistant 60 Implantable Cardioverter Defibrillator 60 failure ADHF 60 ATACAND 60 Patients Treated 60 Urinary Incontinence 60 Pooled Analysis 60 Gastric Cancer 60 Stent Restenosis 60 Surgical Treatment 60 Patients Treated With 60 Lung Tumors 60 Breast Density 60 Antitumor Activity 60 Bronchiectasis 60 Dual Antiplatelet Therapy 60 Thrombolysis 60 Ankylosing Spondylitis 60 Treating Chronic 60 Aortic Stenosis 60 Prolongs Survival 60 either acutely decompensated 60 Complicated Skin 60 Anticoagulation 60 Valvular 60 Bloodstream Infections 60 Renal Failure 60 Newly Diagnosed 60 Myocardial Infarction 60 Restenosis 60 Predict Risk 60 Phase 2b Trial 60 Unfractionated Heparin 60 Dilated Cardiomyopathy 60 Hypertensive Patients 60 Controlled Trial 60 Tiotropium 60 Exacerbations 60 Phase 2b Clinical Trial 60 Replacement Therapy 60 Blood Pressure Monitoring 60 Cardiac Resynchronization 60 Malignant Glioma 60 Circulatory Support 60 Endarterectomy 60 Tyrosine Kinase Inhibitor 60 Benign Prostatic Hyperplasia BPH 59 Bipolar Depression 59 Pediatric Patients 59 Metastatic Cancer 59 Post Operative 59 unstable angina UA 59 overactive bladder syndrome 59 Improves Survival 59 Carotid 59 Oral Mucositis 59 Artery Disease 59 Critical Limb Ischemia CLI 59 Fungal Infections 59 Adjuvant Chemotherapy 59 Embolization 59 Peripheral Vascular Disease 59 Patency 59 Lung Cancer Trial 59 Autoimmune Diseases 59 Novel Oral 59 Randomized Clinical Trial 59 Severe Asthma 59 Decompensated Heart Failure 59 NYHA Class III 59 Refractory Angina 59 Investigational Treatment 59 Risk Stratification 59 Invasive Breast Cancer 59 Investigational Drug 59 Demonstrates Positive 59 Efficacy Trial 59 Nilotinib 59 ADHF 59 NAVISTAR R 59 Inflammatory Markers 59 Enlarged Prostate 59 Anticoagulants 59 Implantable Cardiac 59 Naive Patients 59 Insulin Resistance 59 Liver Failure 59 Pulmonary Artery 59 Invasive Fungal Infections 59 Peripheral Arterial 59 Advanced Melanoma 59 Venous Thromboembolism 59 Adjunctive 59 Renal Cancer 59 Pivotal Study 59 Thromboembolism 59 Clinical Outcomes 59 Rheos System 59 Atrial Fibrillation AF 59 Intracerebral Hemorrhage 59 Completes Enrollment 59 Peptic Ulcer 59 acutely decompensated heart 59 Treating Heart Failure 59 Ranolazine 59 Vulnerable Plaque 59 Kidney Transplant Patients 59 EECP R 59 Ventricular Assist Devices 59 Prevent Stroke 59 Left Ventricular Hypertrophy 59 II Clinical Trial 59 Diabetic Neuropathy 59 Atopic Dermatitis 59 Pivotal Phase III 59 Rilonacept 59 Cardiometabolic 59 Chronic Bronchitis 59 Non Alcoholic Fatty 59 Pediatric Asthma 59 Decitabine 59 Valsartan 59 Diabetic Foot Ulcer 59 Phase III Trial 59 ARIXTRA R 59 Renal Anemia 59 Patient Enrollment 59 Plaque Psoriasis 59 Delayed Graft Function 59 Phase III Clinical Trial 59 Chronic Hepatitis B 59 Antihypertensive 58 Fracture Risk 58 Immunosuppression 58 Less Invasive 58 Soft Tissue Sarcoma 58 Advanced Heart Failure 58 Diabetic Retinopathy 58 Ischaemic 58 Fibromyalgia Syndrome 58 Prospective Multicenter 58 Relapsed Multiple Myeloma 58 Ventricular Tachycardia 58 Glycemic Control 58 Phase IIb Trial 58 unstable angina pectoris 58 Antiviral Therapy 58 Metastatic Colorectal Cancer 58 Endovascular Treatment 58 Lung Cancer Survival 58 Multicenter Phase 58 Phase 2a Clinical Trial 58 Treatment Outcome 58 decompensated heart failure 58 PICSO ® 58 Breast Cancer Treatment 58 Myoblast 58 Hip Fractures 58 Adult Stem Cell Therapy 58 Investigational Agent 58 Premature Infants 58 Idiopathic Pulmonary Fibrosis 58 Prostate Cancer Patients 58 Arrhythmias 58 Critically Ill Patients 58 Aneurysm Repair 58 Mycophenolate Mofetil 58 Single Dose 58 Hepatocellular Carcinoma 58 Antiplatelet Therapy 58 Surgical Procedures 58 Obese Teens 58 Non Inferiority 58 Endometrial Cancer 58 Slow Progression 58 Treatment Naive Patients 58 Coagulation 58 Statin Therapy 58 Autoimmune Disease 58 Rheumatoid Arthritis 58 Treatment Options 58 Hypertensive 58 Migraine Headaches 58 Sustained Efficacy 58 Renal Function 58 Aliskiren 58 Pivotal Clinical Trial 58 Chronic Kidney Disease 58 First Patient Enrolled 58 Vascular Disease 58 Clinical Trial Evaluating 58 Follicular Lymphoma 58 Systolic Hypertension 58 STRIDE PD 58 Chronic Renal Failure 58 Myelodysplastic Syndrome MDS 58 Hepatic Encephalopathy 58 Atypical Hemolytic Uremic Syndrome 58 angiotensin converting enzyme inhibitors 58 Diabetic Neuropathic Pain 58 Orthostatic Hypotension 58 Nicotine Vaccine 58 Blood Glucose 58 von Willebrand Disease 58 Interstitial Cystitis 58 mildly symptomatic 58 Knee Osteoarthritis 58 EURIDIS 58 Pegylated Interferon 58 Therapy Evaluation 58 Multicenter 58 Study Showed 58 Stem Cell Transplants 58 Migraine Pain 58 Sudden Cardiac Death 58 Pivotal Phase 58 Pivotal Trial 58 Monotherapy 58 refractory angina 58 Fabry Disease 58 Cardiac Marker 58 Thrombotic 58 tachyarrhythmia 58 Atrial 58 Chronic Myelogenous Leukemia 58 Endovascular Repair 58 Chronic Constipation 58 Malignant Melanoma 58 Eye Diseases 58 Multicenter Trial 58 Patients Enrolled 58 Coronary Arteries 58 Phase IIb Clinical Trial 58 Esophageal 58 valvular disease 58 Total Knee Replacement 58 Acute Stroke 58 relapsing multiple sclerosis 58 Stress Incontinence 58 Myelofibrosis 58 Patients Suffering 58 PRoFESS 58 Left Ventricular Dysfunction 58 Neovascular Age Related Macular 57 Perindopril 57 Chronic Pelvic Pain 57 Ambulatory Blood Pressure 57 Preterm Delivery 57 atypical Hemolytic Uremic Syndrome 57 Inhaled Corticosteroids 57 Kidney Function 57 Left Ventricular Assist 57 Arterial Disease 57 acute decompensated heart 57 Randomized Phase III 57 Acute Myocardial Infarction AMI 57 Respiratory Distress 57 IABP 57 ischemic cardiomyopathy 57 Varicose Veins 57 Renal Impairment 57 Cardiovascular Disease Risk 57 Atherosclerotic 57 Catheter Associated 57 Premenopausal Women 57 Heart Transplantation 57 Carotid Endarterectomy 57 Postmenopausal Women 57 Reduces Mortality 57 HER2 Positive Breast Cancer 57 Phase III Pivotal 57 Pulmonary Hypertension 57 Statistically Significant 57 Localized Prostate Cancer 57 Enzyme Replacement Therapy 57 Coherex FlatStent 57 NIDDM 57 Fondaparinux 57 Gestational Diabetes 57 Hepatitis C Virus 57 Non Alcoholic Steatohepatitis 57 Study Evaluating 57 Diabetic Ulcers 57 Infected Patients 57 Anthracycline 57 Adjuvant Treatment 57 CABG Surgery 57 Phase Ib Clinical Trial 57 Myeloma Patients 57 Drug Prevents 57 Hemodialysis Patients 57 Pulse Oximetry 57 See CLINICAL PHARMACOLOGY 57 Platelet Inhibition 57 Breast Cancer Patients 57 Differential Diagnosis 57 Phase 2a Trial 57 Spinal Fusion 57 Long Term Survival 57 Survival Rates 57 multicenter prospective 57 Liver Injury 57 AA Amyloidosis 57 Subarachnoid hemorrhage 57 complement inhibitor eculizumab 57 Remote Patient Monitoring 57 Acute MI 57 Bladder Cancer 57 Metabolic Disorder 57 Heart Failure Treatment 57 Clinical Efficacy 57 Atherothrombosis 57 Acute myocardial infarction 57 Medtronic CoreValve ® 57 Is Well Tolerated 57 Afib 57 Bare Metal Stent 57 HeFH 57 Chronic Hepatitis C 57 AVONEX ® 57 Anticancer Activity 57 metastatic malignant 57 Coronary Artery Disease 57 Hypercholesterolemia 57 Iron Deficiency Anemia 57 silent ischemia 57 Artificial Pancreas 57 Psychiatric Disorders 57 Bosutinib 57 Inhaled Nitric Oxide 57 FDA Approvals 57 Antiplatelet 57 Childhood Asthma 57 Deep Venous Thrombosis 57 Hemodynamic 57 Paroxysmal 57 Aortic Valve Replacement 57 Phase 2b Study 57 Stomach Cancer 57 Restless Legs Syndrome 57 Eluting Stent 57 JAK Inhibitor 57 Primary Hypercholesterolemia 57 Randomized Controlled Trials 57 Aortic Aneurysms 57 CT Angiography 57 Systemic Sclerosis 57 Esophageal Cancer 57 intermittent claudication 57 Hormone Refractory Prostate Cancer 57 functional mitral regurgitation 57 Advanced Pancreatic Cancer 57 Laryngeal Cancer 57 Electrical Stimulation 57 Myelodysplastic Syndrome 57 Novel Compound 57 Drug Eluting 57 Thromboembolic 57 Severe Primary IGFD 57 Unstable angina 57 stable angina pectoris 57 Clinical Trial Data 57 Benign Prostatic Hyperplasia 57 Prediabetes 57 Defibrillation 57 Sepsis 57 Colorectal Cancer Patients 57 Relapsed Refractory 57 Intravenous Formulation 57 Genes Predict 57 Shows Efficacy 57 antiarrhythmic drug 57 Pharmacokinetic Study 57 Randomized Controlled Trial 57 Mouse Model 57 Chronic HCV 57 Bronchopulmonary Dysplasia 57 Insulin Delivery 57 Improves Quality 57 Prostate Biopsy 57 Proteinuria 57 Clinical Evaluation 57 Asthma COPD 57 Randomized Controlled 57 Ozarelix 57 Bucindolol 57 Previously Treated 57 Non Invasive Treatment 57 Acute Coronary Syndromes ACS 57 Cypher Stent 57 Randomized Double blind 57 Therapy Improves 57 Occlusive Disease 56 Survival Benefit 56 Hyperlipidemia 56 Eculizumab 56 Thyroid Disease 56 Skin Lesions 56 Systemic Lupus Erythematosus 56 Aggressive Reduction 56 Fibromyalgia Pain 56 Glycemia 56 DuraHeart TM 56 Comorbidities 56 Skeletal Muscle 56 Cardiovascular Events 56 valve implantation 56 Randomized Clinical Trials 56 Angioedema 56 Hypotension 56 metastatic neuroendocrine tumors 56 Combination Therapy 56 Iron Deficiency 56 Bone Metastases 56 failure NYHA 56 Generalized Anxiety Disorder 56 Randomized Double Blind 56 Borderline Personality Disorder 56 Drug Coated Stents 56 Gene Mutation 56 Vascular Grafts 56 Prolongs Life 56 RE MODEL 56 Systemic Lupus Erythematosus SLE 56 Initiates Clinical Trial 56 Parenteral Nutrition 56 Nonalcoholic Steatohepatitis 56 Preclinical Models 56 Recurrent Ovarian Cancer 56 Telemonitoring 56 Meta Analysis 56 Gastric Bypass Surgery 56 mechanical thrombectomy 56 Transplant Patients 56 Glucose Control 56 Diabetes Hypertension 56 Golimumab 56 Randomized Phase 56 Nephropathy 56 Prostate Cancer Treatment 56 bronchial hyperresponsiveness 56 Total Hip Replacement 56 Initiate Clinical Trial 56 Diabetic Eye 56 Cholesterol Levels 56 Hemorrhagic Stroke 56 Interventional Procedures 56 Aortic Valve 56 Randomised 56 Castration Resistant Prostate Cancer 56 Renal Disease 56 Hepatitis C Antiviral 56 unfractionated heparin UFH 56 C Reactive Protein 56 Irritable Bowel 56 Schizophrenia Treatment 56 Total Knee Arthroplasty 56 Fibrosis 56 Blood Pressure Lowering 56 Corneal Transplant 56 Appears Safe 56 Female Sexual Arousal 56 First Patient Treated 56 chronic myocardial ischemia 56 Mechanical Circulatory Support 56 Phase IIIb 56 Minimally Invasive Procedure 56 Neuroendocrine Tumors 56 reflux disease GERD 56 Aggressive Prostate Cancer 56 cytomegalovirus infection 56 Neurostimulation 56 Stem Cell Transplant 56 Paroxysmal Nocturnal Hemoglobinuria PNH 56 myocardial infarction ventricular fibrillation 56 hyperphenylalaninemia HPA due 56 Cardiac Rhythm 56 Ventricular Assist Device 56 Peripheral Neuropathy 56 Newly Diagnosed Patients 56 Gene Linked 56 NYHA Class 56 Practice Patterns 56 Demonstrates Efficacy 56 Cognitive Function 56 Combination REOLYSIN R 56 cardiac resynchronisation therapy 56 angiotensin receptor blocker ARB 56 Prognostic Factors 56 Hydroxyurea 56 Placebo Controlled Study 56 Arrhythmogenic 56 Stem Cell Treatment 56 Cardiac Arrhythmias 56 Lowers Risk 56 Image Guided 56 candesartan cilexetil 56 Lymphocytic 56 Immunosuppressant 56 Multicenter Study 56 Prevent Heart 56 ACE Inhibitor 56 Demonstrates Sustained 56 Muscle Wasting 56 Osteoarthritis Patients 56 Schizoaffective Disorder 56 Double Blind Placebo 56 Ejection Fraction 56 Clostridium difficile Infection 56 Advanced Renal Cell 56 Diuretic 56 nicardipine 56 Microplasmin 56 Stress Urinary Incontinence 56 Edge STudy 56 Magnetic Stimulation 56 Bosentan 56 Neoadjuvant Chemotherapy 56 Pneumococcal Vaccine 56 Dose Ranging Study 56 Trigeminal Neuralgia 56 Pivotal Trials 56 Aortic Dissection 56 Bronchodilator 56 Cutaneous T 56 Rotavirus Vaccine 56 B Cell Malignancies 56 Symptom Relief 56 Neoadjuvant 56 Uterine Fibroid Embolization 56 Phase IIa Clinical Trial 56 TMS Therapy 56 leukemia AML 56 Radiofrequency Ablation RFA 56 Sustained Reduction 56 Dose Escalation 56 Tumor Growth 56 Advanced Prostate Cancer 56 GI motility disorders 56 Melphalan 56 acute coronary syndromes ACS 56 CRT ICD 56 Increased Mortality 56 Short Stature 56 Mitral Valve Repair 56 Hormone Receptor Positive 56 Blood Clots 56 Treatment Regimen 56 Angiographic 56 Myocardial 56 serum phosphorous 56 Viral Infection 56 Clinical Trial 56 CARE HF 56 Hemoglobin Levels 56 Stent Implantation 56 HCV Protease Inhibitor 56 Drug Eluting Coronary Stent 56 Nerve Stimulation 56 Insulin Pumps 56 Completes Patient Enrollment 56 Venous Thrombosis 56 Visceral Fat 56 Neurodegenerative 56 Diabetic Nephropathy 56 Long Term Outcomes 56 Cancer Treatments 56 Heart Transplant Recipients 56 Chronic Fatigue Syndrome CFS 56 Chronic Insomnia 56 aortic valve stenosis 56 Adjuvant Therapy 56 CardioFit 55 cystic fibrosis bronchiectasis 55 occlusive disease 55 HALO# [002] 55 Claudication 55 Frozen Shoulder Syndrome 55 Recurrent Breast Cancer 55 Anxiety Depression 55 Major Depressive Disorder 55 Continuous Glucose Monitoring 55 Previously Untreated 55 Sapacitabine 55 Trial Evaluating 55 Ulcerative Colitis 55 Innate Immune 55 Chronic Rhinosinusitis 55 First Patient Dosed 55 Initiates Phase III 55 induce orthostatic hypotension 55 Acute Pancreatitis 55 Randomized Double Blind Placebo 55 Pelvic Pain 55 Antipsychotic Medications 55 oxypurinol 55 Mantle Cell Lymphoma 55 Suicidality 55 Implantable Device 55 Systolic Blood Pressure 55 Migraine Headache 55 Transplant Rejection 55 Diabetes Complications 55 Transcatheter 55 Thiazolidinediones 55 Tipranavir 55 Low Incidence 55 transcranial Doppler ultrasound 55 Electroencephalography 55 Drug Candidate 55 Chronic Wounds 55 antiplatelet medications 55 Hypertrophy 55 Diabetic Macular Edema DME 55 stem cell engraftment 55 Treated Patients 55 Insulin Pump 55 Corticosteroid 55 Significantly Improves 55 Brain Metastases 55 peripheral arterial disease 55 Sleep Disordered Breathing 55 Late Onset 55 HIV HCV coinfected 55 Cognitive Problems 55 Thyroid Hormone 55 Proves Effective 55 paroxysmal atrial fibrillation 55 Diagnostic Assay 55 Microalbuminuria 55 chronic thromboembolic pulmonary 55 Abdominal Pain 55 Treatment Naive 55 Cypher Sirolimus 55 Effective Treatments 55 Atrial Fibrillation Treatment 55 Robotic Assisted 55 infective endocarditis 55 Advanced Colorectal Cancer 55 LDL Cholesterol 55 Stenting 55 Showed Significant 55 Nonalcoholic Fatty Liver Disease 55 Excessive Sweating 55 Endothelial Function 55 Panic Disorder 55 NYHA 55 Abdominal Aortic Aneurysm 55 Blood Cancers 55 Intervention Effectiveness 55 Recurrent Glioblastoma 55 Irritable Bowel Syndrome IBS 55 Drug Eluting Stent 55 overt nephropathy 55 ischemic complications 55 metastatic GIST 55 DVT PE 55 Initiated Phase 55 ANN INTERN MED 55 hypercholesterolaemia 55 Leukemias 55 Sirolimus Eluting Stent 55 Medication Adherence 55 Autologous Stem Cell Transplantation 55 Demonstrates Significant 55 Successfully Completes Phase 55 Randomized Trials 55 Placebo Controlled Trial 55 Epratuzumab 55 acute PAO 55 Early Diagnosis 55 Chest Pain 55 Dyslipidemia 55 NATRECOR R 55 Enhanced External Counterpulsation 55 Implantable Defibrillator 55 Depressive Symptoms 55 Peritoneal Dialysis 55 coronary intervention 55 patientswith 55 Treatment Shows Promise 55 Interstitial cystitis 55 T2DM 55 Squamous Cell Carcinoma 55 mild renal insufficiency 55 BENICAR 55 Initiate Phase 55 TMC# C# 55 Treatment Experienced 55 Slows Progression 55 prospective multicentre 55 disease GERD 55 Emerging Therapies 55 Embolic 55 Partial Nephrectomy 55 Metastatic Renal Cell Carcinoma 55 Renal Cell Cancer 55 Natalizumab 55 Uterine Fibroids 55 Enoxaparin 55 Novel Approaches 55 stable angina 55 MADIT II 55 Atacand ® 55 invasive candidiasis 55 Prostate Screening 55 Study Demonstrates 55 Cluster Headaches 55 Urinary Tract Infections 55 MRSA Infections 55 Reduce Mortality 55 Diamyd Medical Diamyd 55 Low Dose 55 Metabolic Disease 55 Insulin Therapy 55 Coronary Intervention 55 Osteoarthritis Pain 55 Coronary Revascularization 55 CLOTS 55 Sinus Infections 55 Gastrointestinal GI 55 Sipuleucel T 55 CYT# potent vascular disrupting 55 Insulin Sensitivity 55 Successfully Treated 55 resynchronization therapy 55 Endothelial Dysfunction 55 acute myocardial infarction AMI 55 Feasibility Trial 55 Inhaled Insulin 55 tachyarrhythmias 55 Myocardial Perfusion Imaging 55 Efficacious 55 Anemia Drug 55 Improve Patient Outcomes 55 nonfatal myocardial infarction MI 55 Node Positive 55 Eisenmenger syndrome 55 Fully Covered Stent 55 Shows Promise Against 55 Often Misdiagnosed 55 Ischemic Heart Disease 55 Interpersonal Psychotherapy 55 Bacterial Infections 55 Blood Glucose Monitor 55 SHPT 55 Solid Tumors 55 Oral Insulin 55 cardiogenic shock 55 aldosterone antagonists 55 Thyroid Cancer 55 Beta Blockers 55 Treatment Naïve 55 Acute Myeloid Leukemia 55 Brain Aneurysms 55 Non Invasive 55 Immune Mediated 55 Significantly Improved 55 Gout Drug 55 Asymptomatic 55 Portal Hypertension 55 HCV Genotype 55 Improved Survival 55 Who Underwent 55 Clinical Documentation 55 Spinal Implant 55 Percutaneous Tibial Nerve Stimulation 55 Rheumatoid 55 Combo Therapy 55 vWD 55 Kidney Stones 55 bacterial prostatitis 55 cinacalcet 55 Biphasic 55 Coronary Heart Disease 55 Uric Acid 55 Controlled Study 55 Morbid Obesity 55 Multiple Myeloma Patients 54 Vertebral Compression Fracture 54 Rare Genetic 54 peritumoral brain edema 54 Hematopoietic Stem Cell Transplantation 54 Male Infertility 54 Infantile Spasms 54 Chronic Kidney 54 Dyskinesia 54 Periodontal Disease 54 Injury ALI 54 Acute Myelogenous Leukemia AML 54 Chronic Lung 54 Airway Bypass 54 Pregnancy Outcome 54 Inflammatory Disease 54 Coronary Artery Bypass Surgery 54 Cancer Patients Treated 54 Drug Shows Promise 54 Causes Symptoms 54 mixed hyperlipidemia 54 exocrine pancreatic insufficiency EPI 54 keloid scarring 54 Glioblastoma Multiforme 54 NDA Submission 54 Diabetic Kidney Disease 54 Complication Rates 54 Mortality Risk 54 Postmenopausal Osteoporosis 54 Omacetaxine 54 diabetic nephropathy 54 Heart Failure Trial 54 prospective randomized multicenter 54 Genetic Variation 54 Echocardiographic 54 Carotid Artery 54 Hepatocellular Carcinoma HCC 54 PEGylated interferon beta 1a 54 IV NSCLC 54 Clinically Significant 54 TAXUS Stent 54 Blood Glucose Testing 54 Adjunctive Therapy 54 Brain Aneurysm 54 Ovarian Cancer Patients 54 Breast Ultrasound 54 Cardiovascular Risk 54 Prostate Surgery 54 ISTODAX ® 54 unstable angina chest 54 Pharmacokinetics PK 54 Medication Errors 54 Cancer Recurrence 54 recurrent sinusitis 54 Well Tolerated 54 Antiepileptic Drug 54 NYHA functional class 54 Angiogenic 54 Radical Prostatectomy 54 Cardiovascular Mortality 54 familial amyloidotic polyneuropathy FAP 54 R lenalidomide 54 Immunodeficiency 54 Cardiac Disease 54 Progenitor Cells 54 Confirmatory Phase 54 Erythropoietic 54 relapsing remitting MS RRMS 54 TNF antagonist 54 Arrhythmia 54 Symptom Scale 54 Pulmonary Arterial Hypertension PAH 54 Radiation Exposure 54 Tumor Response 54 Female Stress Urinary 54 NeuroStar TMS Therapy 54 Menopausal Symptoms 54 Radiation Treatment 54 Treating Depression 54 Depressive Disorders 54 immune thrombocytopenic purpura 54 Oral Cavity 54 GOUT 54 Prognostic Value 54 Expanded Indication 54 Helicobacter pylori eradication 54 recurrent glioblastoma multiforme 54 Growth Hormone Deficiency 54 CIMZIA TM certolizumab pegol 54 primary percutaneous coronary 54 Hepatitis C Genotype 54 recurrent glioma 54 Levels Linked 54 Therapy Shows Promise 54 Inflammatory Bowel Disease 54 Implantable Cardioverter Defibrillators 54 Initiates Phase 2b 54 Demonstrated Significant 54 arthritis PsA 54 Arteriovenous

Back to home page